Vertex Stock: Slowing Growth, But It’s Attractively Valued Now

koto_feja/E+ via Getty Images
Investment Thesis
Vertex Pharmaceuticals Incorporated (VRTX) is a biotech company specializing in treating genetic Cystic Fibrosis. The company sells four different combinations of drugs to treat patients with Cystic Fibrosis,…

Click here to view the original article.